Schizotypal personality disorder

Schizotypal personality disorder (STPD or SPD), also known as schizotypal disorder, is a mental and behavioral disorder.[1] DSM classification describes the disorder specifically as a personality disorder characterized by thought disorder, paranoia, a characteristic form of social anxiety, derealization, transient psychosis, and unconventional beliefs. People with this disorder feel pronounced discomfort in forming and maintaining social connections with other people, primarily due to the belief that other people harbor negative thoughts and views about them.[2] Peculiar speech mannerisms and socially unexpected modes of dress are also characteristic. Schizotypal people may react oddly in conversations, not respond, or talk to themselves.[2] They frequently interpret situations as being strange or having unusual meaning for them; paranormal and superstitious beliefs are common. Schizotypal people usually disagree with the suggestion their thoughts and behaviors are a 'disorder', and seek medical attention for depression or anxiety instead.[3] Schizotypal personality disorder occurs in approximately 3% of the general population and is more commonly diagnosed in males.[4]

Schizotypal disorder
People with STPD often feel isolated from society.
SpecialtyPsychiatry
SymptomsIdeas of reference, unusual beliefs, perceptual Illusions, odd thinking and speech, suspiciousness, inappropriate affect, strange behavior, lack of friends, paranoid social anxiety
ComplicationsSchizophrenia, substance use disorder, major depressive disorder
Usual onset10–20 year old
DurationLifelong
Risk factorsFamily history
Differential diagnosisCluster A personality disorders, borderline personality disorder, avoidant personality disorder, autism spectrum disorder, social anxiety disorder, ADHD-PI (ADD)
FrequencyEstimated 3% of general population

History

The term "schizotype" was first coined by Sandor Rado in 1956 as a portmanteau of "schizophrenic phenotype".[5] STPD is classified as a cluster A personality disorder, also known as the "odd or eccentric" cluster.

STPD as a proper diagnosis was first introduced in 1980, with the release of the DSM-III. The diagnosis was created to fill the gap between Borderline Personality Disorder (BPD) and moderate schizophrenia-like symptoms. Because of this, many early studies were either seeking to distinguish it from other diagnoses, specifically BPD, or identify its utility in recognizing non-clinical people who were genetically predisposed to schizophrenia.[6]

Very few changes were made from the DSM-IV-TR to the DSM-V in terms of the diagnostic criteria. [6]

Causes

Genetic

Schizotypal personality disorder is widely understood to be a "schizophrenia spectrum" disorder. Rates of schizotypal personality disorder are much higher in relatives of individuals with schizophrenia than in the relatives of people with other mental illnesses or in people without mental illness. Technically speaking, schizotypal personality disorder may also be considered an "extended phenotype" that helps geneticists track the familial or genetic transmission of the genes that are implicated in schizophrenia pathogenesis.[7] But there is also a genetic connection of STPD to mood disorders and depression in particular.[8] Prediction of schizophrenia based on schizotypal traits has a higher accuracy for individuals with high genetic risk for STPD.[9]

Social and environmental

Unique environmental factors, which differ from shared sibling experiences, have been found to play a role in the development of STPD and its dimensions.[6] There is now evidence to suggest that parenting styles, early separation, trauma/maltreatment history (especially early childhood neglect) can lead to the development of schizotypal traits.[10][11] Neglect or abuse, trauma, or family dysfunction during childhood may increase the risk of developing schizotypal personality disorder. There is also evidence indicating influenza in the prenatal environment could have an effect on development of STPD.[12] Over time, children learn to interpret social cues and respond appropriately but for unknown reasons this process does not work well for people with this disorder.[13]

Schizotypal personality disorders are characterized by a common attentional impairment in various degrees that could serve as a marker of biological susceptibility to STPD.[14] The reason is that an individual who has difficulties taking in information may find it difficult in complicated social situations where interpersonal cues and attentive communications are essential for quality interaction. This might eventually cause the individual to withdraw from most social interactions, thus leading to asociality.[14]

Diagnosis

Screening

There are various methods of screening for schizotypal personality. The Schizotypal Personality Questionnaire (SPQ) measures nine traits of STPD using a self-report assessment. The nine traits referenced are Ideas of Reference, Excessive Social Anxiety, Odd Beliefs or Magical Thinking, Unusual Perceptual Experiences, Odd or Eccentric Behavior, No Close Friends, Odd Speech, Constricted Affect, and Suspiciousness. A study found that of the participants who scored in the top 10th percentile of all the SPQ scores, 55% were clinically diagnosed with STPD.[15] A method that measures the risk for developing psychosis through self-reports is the Wisconsin Schizotypy Scale (WSS).[16] The WSS divides schizotypal personality traits into 4 scales for Perceptual Aberration, Magical Ideation, Revised Social Anhedonia, and Physical Anhedonia.[17][18][3] A comparison of the SPQ and the WSS suggests that these measures should be cautiously used for screening purposes of STPD.[18]

DSM-5

In the American Psychiatric Association's DSM-5, schizotypal personality disorder is defined as a "pervasive pattern of social and interpersonal deficits marked by acute discomfort with, and reduced capacity for, close relationships as well as by cognitive or perceptual distortions and eccentricities of behavior, beginning by early adulthood and present in a variety of contexts."[3]

At least five of the following symptoms must be present:

  • ideas of reference
  • strange beliefs or magical thinking that influences behavior and is inconsistent with subcultural norms (e.g., superstitiousness, belief in clairvoyance, telepathy, or “sixth sense”, bizarre fantasies or preoccupations)
  • abnormal perceptual experiences, including bodily illusions
  • strange thinking and speech (e.g., vague, circumstantial, metaphorical, overelaborate, or stereotyped)
  • inappropriate or constricted affect
  • strange behavior or appearance
  • excessive social anxiety that does not diminish with familiarity and tends to be associated with paranoid fears rather than negative judgments about self

These symptoms must not occur only during the course of a disorder with similar symptoms (such as schizophrenia or autism spectrum disorder).[3]

The symptoms of "lacking close friends" and "suspiciousness or paranoia" have been used for diagnosing STPD by the DSM-V. These criteria overlap with symptoms for Paranoid personality disorder (PPD) and Schizoid personality disorder (SzPD), making these symptoms not as useful when distinguishing STPD from other personality disorders. [6]

ICD-10

The World Health Organization's ICD-10 uses the name schizotypal disorder (F21). It is classified as a clinical disorder associated with schizophrenia, rather than a personality disorder as in DSM-5.[19]

The ICD definition is:

A disorder characterized by eccentric behavior and anomalies of thinking and affect which resemble those seen in schizophrenia, though no definite and characteristic schizophrenic anomalies have occurred at any stage. There is no dominant or typical disturbance, but any of the following may be present:

  • Inappropriate or constricted affect (the individual appears cold and aloof);
  • Behavior or appearance that is odd, eccentric or peculiar;
  • Poor rapport with others and a tendency to withdraw socially;
  • Odd beliefs or magical thinking, influencing behavior and inconsistent with subcultural norms;
  • Suspiciousness or paranoid ideas;
  • Obsessive ruminations without inner resistance;
  • Unusual perceptual experiences including somatosensory (bodily) or other illusions, depersonalization or derealization;
  • Vague, circumstantial, metaphorical, over-elaborate or stereotyped thinking, manifested by odd speech or in other ways, without gross incoherence;
  • Occasional transient quasi-psychotic episodes with intense illusions, auditory or other hallucinations and delusion-like ideas, usually occurring without external provocation.

The disorder runs a chronic course with fluctuations of intensity. Occasionally it evolves into overt schizophrenia. There is no definite onset and its evolution and course are usually those of a personality disorder. It is more common in individuals related to people with schizophrenia and is believed to be part of the genetic "spectrum" of schizophrenia.

Diagnostic guidelines

This diagnostic rubric is not recommended for general use because it is not clearly demarcated either from simple schizophrenia or from schizoid or paranoid personality disorders, or possibly autism spectrum disorders as currently diagnosed. If the term is used, three or four of the typical features listed above should have been present, continuously or episodically, for at least two years. The individual must never have met criteria for schizophrenia itself. A history of schizophrenia in a first-degree relative gives additional weight to the diagnosis but is not a prerequisite.

Treatment

Medication

STPD is rarely seen as the primary reason for treatment in a clinical setting, but it often occurs as a comorbid finding with other mental disorders. When patients with STPD are prescribed pharmaceuticals, they are usually prescribed neuroleptics, also known as antipsychotics, of the sort used to treat schizophrenia; however, the use of neuroleptic drugs in the schizotypal population is in great doubt.[20] While people with schizotypal personality disorder and other attenuated psychotic-spectrum disorders may have a good outcome with neuroleptics in the short term, long-term follow-up suggests significant impairment in daily functioning compared to schizotypal and even schizophrenic people without neuroleptic drug exposure.[21] Positive, negative, and depressive symptoms were shown to be improved by the used of olanzapine, a neuroleptic. [22] Those with comorbid OCD and STPD were most positively affected by the use of olanzapine, and showed worse outcomes with the use of clomipramine, an antidepressant. [23]

Antidepressants are also sometimes prescribed, whether for STPD proper or for comorbid anxiety and depression.[20] However, there is some ambiguity in the efficacy of antidepressants, as many studies have only tested people with STPD and comorbid obsessive-compulsive disorder or borderline personality disorder. They have shown little efficacy for treating dysthymia and anhedonia related to STPD. [6]

Both of these medications are the most frequently prescribed medication for STPD, though the use and efficacy of them should be evaluated differently for every case.[22]

The use of stimulants have also shown some efficacy, especially for those with worsened cognitive and attentional issues. Patients that suffer from concurrent psychosis should be monitored more closely if stimulants are used as part of their treatment. [6]

Therapy

According to Theodore Millon, schizotypal personality disorder is one of the easiest personality disorders to identify but one of the most difficult to treat with psychotherapy.[5] Persons with STPD usually consider themselves to be simply eccentric or nonconformist; the degree to which they consider their social nonconformity a problem differs from the degree to which it is considered a problem in psychiatry. It is difficult to gain rapport with people with STPD due to the fact that increasing familiarity and intimacy usually increase their level of anxiety and discomfort.[24]

Group therapy is recommended for persons with STPD only if the group is well structured and supportive. Otherwise, it could lead to loose and tangential ideation.[20] Support is especially important for schizotypal patients with predominant paranoid symptoms, because they will have a lot of difficulties even in highly structured groups.[25]

Comorbidity

Schizotypal personality disorder frequently co-occurs with major depressive disorder, dysthymia and social phobia.[26] Furthermore, sometimes schizotypal personality disorder can co-occur with obsessive–compulsive disorder, and its presence appears to affect treatment outcome adversely.[27] Some people with a clinical diagnosis of OCD have been found to also possess many schizotypal personality traits resulting in what can be called ‘schizotypal OCD’.[28] Without proper treatment, STPD tendencies, such as magical thinking and paranoid ideation, could worsen the symptoms of OCD in an individual.[29][30] [31]

In terms of comorbidity with other personality disorders, schizotypal personality disorder has high comorbidity with schizoid and paranoid personality disorder, the other two 'Cluster A' conditions.[32] Studies have found that cognitive impairment was worse in those with PPD or STPD, but the co-occurrence of the two had little impact.[6] It also has significant comorbidity with borderline personality disorder and narcissistic personality disorder.[30]

Some schizotypal people go on to develop schizophrenia,[33] but most of them do not.[34] There are dozens of studies showing that individuals with schizotypal personality disorder score similar to individuals with schizophrenia on a very wide range of neuropsychological tests. Cognitive deficits in patients with schizotypal personality disorder are very similar to, but quantitatively milder than, those for patients with schizophrenia.[35] A 2004 study, however, reported neurological evidence that did "not entirely support the model that SPD is simply an attenuated form of schizophrenia".[36]

Epidemiology

Reported prevalence of STPD in community studies ranges from 1.37% in a Norwegian sample, to 4.6% in an American sample.[3][6]A large American study found a lifetime prevalence of 3.9%, with somewhat higher rates among men (4.2%) than women (3.7%).[4] It may be uncommon in clinical populations, with reported rates of up to 1.9%.[3]

There is little known about the real world effect that STPD has on individuals. There does seem to be a relationship between STPD and not living on one's own or having a Bachelor's degree. People with STPD also seemed to be paid lower hours wages when compared to a healthy control group. The disorder also seems to be related to lack of employment, though this is specifically related to worsened cognitive impairment. [6]

Chance of STPD were seen highest in Black women, low socioeconomic people, and people separated from their partners, with the lowest rates in Asian men.[6]

Together with other cluster A personality disorders, it is also very common among homeless people who show up at drop-in centers, according to a 2008 New York study. The study did not address homeless people who do not show up at drop-in centers.[37]

Adolescent cannabis users have an increased likelihood of self-reporting and possessing schizotypal personality disorder or traits consistent with STPD.[38][39] Another epidemiological study on suicidal behavior in STPD found that, even when accounted for sociodemographic factors, people with STPD were 1.51 times more likely to attempt suicide. The same study found that people with childhood adversities, specifically abuse by a parent or caretaker, have a strongly significant association with lifetime STPD.[40]

Schizotypal disorder is over diagnosed in Russia and other post-Soviet states.[41]

See also

References

  1. Sartorius N, Henderson A, Strotzka H, Lipowski Z, Yu-cun S, You-xin X, et al. "The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines" (PDF). www.who.int. World Health Organization. bluebook.doc. pp. 77, 83–4. Retrieved 23 June 2021.
  2. Schacter DL, Gilbert DT, Wegner DM (2010). Psychology. Worth Publishers.
  3. Diagnostic and statistical manual of mental disorders : DSM-5. American Psychiatric Association, American Psychiatric Association. 2013. pp. 655–659. ISBN 978-0-89042-555-8. OCLC 830807378.
  4. Pulay AJ, Stinson FS, Dawson DA, Goldstein RB, Chou SP, Huang B, et al. (2009). "Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions". Primary Care Companion to the Journal of Clinical Psychiatry. 11 (2): 53–67. doi:10.4088/PCC.08m00679. PMC 2707116. PMID 19617934.
  5. Millon T (2004). "Chapter 12 – The Schizotypal Personality" (PDF). Personality disorders in modern life. Wiley. p. 403. ISBN 978-0-471-23734-1. OCLC 57291241. Archived from the original (PDF) on 2017-02-07.
  6. Rosell DR, Futterman SE, McMaster A, Siever LJ (July 2014). "Schizotypal personality disorder: a current review". Current Psychiatry Reports. 16 (7): 452. doi:10.1007/s11920-014-0452-1. PMC 4182925. PMID 24828284.
  7. Fogelson DL, Nuechterlein KH, Asarnow RA, Payne DL, Subotnik KL, Jacobson KC, et al. (March 2007). "Avoidant personality disorder is a separable schizophrenia-spectrum personality disorder even when controlling for the presence of paranoid and schizotypal personality disorders The UCLA family study". Schizophrenia Research. Elsevier BV. 91 (1–3): 192–199. doi:10.1016/j.schres.2006.12.023. PMC 1904485. PMID 17306508.
  8. Comer R, Comer G. "Personality Disorders" (PDF). Worth Publishers. Princeton University. Archived (PDF) from the original on 2017-05-17. Retrieved 30 April 2017.
  9. Fonseca-Pedrero E, Ortuño J, Debbané M, Chan RC, Cicero D, Zhang LC, et al. (October 2018). "The Network Structure of Schizotypal Personality Traits". Schizophrenia Bulletin. 44 (suppl_2): S468–S479. doi:10.1093/schbul/sby044. PMC 6188518. PMID 29684178.
  10. Deidre M. Anglina, Patricia R. Cohenab, Henian Chena (2008) Duration of early maternal separation and prediction of schizotypal symptoms from early adolescence to midlife, Schizophrenia Research Volume 103, Issue 1, Pages 143–150 (August 2008)
  11. Howard Berenbaum, Ph.D., Eve M. Valera, Ph.D. and John G. Kerns, Ph.D. (2003) Psychological Trauma and Schizotypal Symptoms, Oxford Journals, Medicine, Schizophrenia Bulletin Volume 29, Number 1 Pp. 143–152
  12. Machón RA, Huttunen MO, Mednick SA, Sinivuo J, Tanskanen A, Bunn Watson J, et al. (March 2002). "Adult schizotypal personality characteristics and prenatal influenza in a Finnish birth cohort". Schizophrenia Research. 54 (1–2): 7–16. doi:10.1016/S0920-9964(01)00346-2. PMID 11853973. S2CID 20875584.
  13. Mayo Clinic Staff. "Schizotypal personality disorder". Mayo Clinic. Archived from the original on 9 March 2012. Retrieved 21 February 2012.
  14. Roitman SE, Cornblatt BA, Bergman A, Obuchowski M, Mitropoulou V, Keefe RS, et al. (May 1997). "Attentional functioning in schizotypal personality disorder". The American Journal of Psychiatry. 154 (5): 655–660. doi:10.1176/ajp.154.5.655. PMID 9137121.
  15. Raine A (1991). "The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria". Schizophrenia Bulletin. 17 (4): 555–564. doi:10.1093/schbul/17.4.555. PMID 1805349.
  16. Winterstein BP, Silvia PJ, Kwapil TR, Kaufman JC, Reiter-Palmon R, Wigert (2011). "Brief assessment of schizotypy: Developing short forms of the Wisconsin Schizotypy Scales". Personality and Individual Differences. 51 (8): 920–924. doi:10.1016/j.paid.2011.07.027.
  17. Schizotypal Disorder Archived 2015-11-02 at the Wayback Machine in ICD-10: Clinical descriptions and guidelines. Archived 2014-03-23 at the Wayback Machine
  18. Gross GM, Mellin J, Silvia PJ, Barrantes-Vidal N, Kwapil TR (October 2014). "Comparing the factor structure of the Wisconsin Schizotypy Scales and the Schizotypal Personality Questionnaire" (PDF). Personality Disorders. 5 (4): 397–405. doi:10.1037/per0000090. PMID 25314229.
  19. Schizotypal Disorder Archived 2015-11-02 at the Wayback Machine in ICD-10: Clinical descriptions and guidelines. Archived 2014-03-23 at the Wayback Machine
  20. Livesley W (2001). Handbook of personality disorders : theory, research, and treatment. Guilford Press. ISBN 978-1-57230-629-5. OCLC 45750508.
  21. Harrow M, Jobe TH, Faull RN, Yang J (October 2017). "A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia". Psychiatry Research. 256: 267–274. doi:10.1016/j.psychres.2017.06.069. PMC 5661946. PMID 28651219.
  22. Koch, Jessa; Modesitt, Taylor; Palmer, Melissa; Ward, Sarah; Martin, Bobbie; Wyatt, Robby; Thomas, Christopher (2016-03-08). "Review of pharmacologic treatment in cluster A personality disorders". The Mental Health Clinician. 6 (2): 75–81. doi:10.9740/mhc.2016.03.75. ISSN 2168-9709. PMC 6007578. PMID 29955451.
  23. Kirchner, Sophie K.; Roeh, Astrid; Nolden, Jana; Hasan, Alkomiet (2018-10-03). "Diagnosis and treatment of schizotypal personality disorder: evidence from a systematic review". npj Schizophrenia. 4 (1): 1–18. doi:10.1038/s41537-018-0062-8. ISSN 2334-265X.
  24. Siever LJ (1992). "Schizophrenia spectrum disorders". Review of Psychiatry. 11: 25–42.
  25. Oldham J, Skodol AE, Bender DS (2005). The American Psychiatric Publishing textbook of personality disorders. American Psychiatric Pub. ISBN 978-1-58562-159-0. OCLC 56733258.
  26. Sutker P (2002). Comprehensive handbook of psychopathology (3rd ed.). Kluwer Academic. ISBN 978-0-306-46490-4. OCLC 50322422.
  27. Murray R (2008). Essential psychiatry (4th ed.). Cambridge University Press. ISBN 978-0-521-60408-6. OCLC 298067373.
  28. Attademo L, Bernardini F (October 2021). "Schizotypal personality disorder in clinical obsessive-compulsive disorder samples: a brief overview". CNS Spectrums. 26 (5): 468–480. doi:10.1017/S1092852920001716. PMID 32713392. S2CID 220796175.
  29. Fossati A, Borroni S (2008). "When 'entities' are as intrusive as obsessions: A case study of the co‐occurrence of obsessive–compulsive disorder and schizotypal personality disorder diagnoses". Personality and Mental Health. 2 (3): 192–200. doi:10.1002/pmh.42.
  30. Pulay AJ, Stinson FS, Dawson DA, Goldstein RB, Chou SP, Huang B, et al. (2009). "Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 national epidemiologic survey on alcohol and related conditions". Primary Care Companion to the Journal of Clinical Psychiatry. 11 (2): 53–67. doi:10.4088/pcc.08m00679. PMC 2707116. PMID 19617934.
  31. Cavanna AE, Robertson MM, Critchley HD (December 2007). "Schizotypal personality traits in Gilles de la Tourette syndrome". Acta Neurologica Scandinavica. 116 (6): 385–391. doi:10.1111/j.1600-0404.2007.00879.x. PMC 2275799. PMID 17986097.
  32. Tasman A (2008). Psychiatry (3rd ed.). Wiley-Blackwell. ISBN 978-0-470-06571-6. OCLC 264703257.
  33. Walker E, Kestler L, Bollini A, Hochman KM (2004). "Schizophrenia: etiology and course". Annual Review of Psychology. Annual Reviews. 55 (1): 401–430. doi:10.1146/annurev.psych.55.090902.141950. PMID 14744221.
  34. Raine A (2006). "Schizotypal personality: neurodevelopmental and psychosocial trajectories". Annual Review of Clinical Psychology. 2: 291–326. doi:10.1146/annurev.clinpsy.2.022305.095318. PMID 17716072.
  35. Matsui M, Sumiyoshi T, Kato K, Yoneyama E, Kurachi M (April 2004). "Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia". Psychological Reports. SAGE Publications. 94 (2): 387–397. doi:10.2466/pr0.94.2.387-397. PMID 15154161. S2CID 41869819.
  36. Haznedar MM, Buchsbaum MS, Hazlett EA, Shihabuddin L, New A, Siever LJ (December 2004). "Cingulate gyrus volume and metabolism in the schizophrenia spectrum". Schizophrenia Research. 71 (2–3): 249–262. doi:10.1016/j.schres.2004.02.025. PMID 15474896. S2CID 28889346.
  37. Connolly AJ, Cobb-Richardson P, Ball SA (December 2008). "Personality disorders in homeless drop-in center clients" (PDF). Journal of Personality Disorders. 22 (6): 573–588. doi:10.1521/pedi.2008.22.6.573. PMID 19072678. Archived from the original (PDF) on 2009-06-17.
  38. Davis GP, Compton MT, Wang S, Levin FR, Blanco C (December 2013). "Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions". Schizophrenia Research. 151 (1–3): 197–202. doi:10.1016/j.schres.2013.10.018. PMC 3877688. PMID 24200416.
  39. Anglin, Deidre M.; Corcoran, Cheryl M.; Brown, Alan S.; Chen, Henian; Lighty, Quenesha; Brook, Judith S.; Cohen, Patricia R. (2012-05-01). "Early cannabis use and Schizotypal Personality Disorder Symptoms from adolescence to middle adulthood". Schizophrenia Research. 137 (1): 45–49. doi:10.1016/j.schres.2012.01.019. ISSN 0920-9964.
  40. Lentz V, Robinson J, Bolton JM (November 2010). "Childhood adversity, mental disorder comorbidity, and suicidal behavior in schizotypal personality disorder". The Journal of Nervous and Mental Disease. 198 (11): 795–801. doi:10.1097/NMD.0b013e3181f9804c. PMID 21048469. S2CID 205882039.
  41. Быкова А. Ю., Беккер Р. А., Быков Ю. В. О трудностях дифференциальной диагностики между первичным деперсонализационно-дереализационным расстройством и шизотипическим расстройством // Siberian Journal of Life Sciences & Agriculture. — 2022. — Т. 14. — №. 1.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.